Department of Immunology, ELTE Eötvös Loránd University, Budapest, Hungary.
MTA-ELTE Complement Research Group, Department of Immunology, ELTE Eötvös Loránd University, Budapest, Hungary.
Front Immunol. 2020 Jul 16;11:1297. doi: 10.3389/fimmu.2020.01297. eCollection 2020.
Complement plays an essential role in the opsonophagocytic clearance of apoptotic/necrotic cells. Dysregulation of this process may lead to inflammatory and autoimmune diseases. Factor H (FH), a major soluble complement inhibitor, binds to dead cells and inhibits excessive complement activation on their surface, preventing lysis, and the release of intracellular material, including DNA. The FH-related (FHR) proteins share common ligands with FH, due to their homology with this complement regulator, but they lack the domains that mediate the complement inhibitory activity of FH. Because their roles in complement regulation is controversial and incompletely understood, we studied the interaction of FHR-1 and FHR-5 with DNA and dead cells and investigated whether they influence the regulatory role of FH and the complement activation on DNA and dead cells. FH, FHR-1, and FHR-5 bound to both plasmid DNA and human genomic DNA, where both FHR proteins inhibited FH-DNA interaction. The FH cofactor activity was inhibited by FHR-1 and FHR-5 due to the reduced binding of FH to DNA in the presence of the FHRs. Both FHRs caused increased complement activation on DNA. FHR-1 and FHR-5 bound to late apoptotic and necrotic cells and recruited monomeric C-reactive protein and pentraxin 3, and . Interactions of the FHRs with pentraxins resulted in enhanced activation of both the classical and the alternative complement pathways on dead cells when exposed to human serum. Altogether, our results demonstrate that FHR-1 and FHR-5 are competitive inhibitors of FH on DNA; moreover, FHR-pentraxin interactions promote opsonization of dead cells.
补体在凋亡/坏死细胞的调理吞噬清除中发挥着重要作用。该过程的失调可能导致炎症和自身免疫性疾病。因子 H (FH),一种主要的可溶性补体抑制剂,与死亡细胞结合并抑制其表面过度的补体激活,防止细胞溶解和细胞内物质(包括 DNA)的释放。FH 相关(FHR)蛋白与 FH 具有共同的配体,由于它们与这种补体调节剂具有同源性,但它们缺乏介导 FH 补体抑制活性的结构域。由于它们在补体调节中的作用存在争议且尚未完全了解,因此我们研究了 FHR-1 和 FHR-5 与 DNA 和死亡细胞的相互作用,并探讨了它们是否影响 FH 的调节作用以及 DNA 和死亡细胞上的补体激活。FH、FHR-1 和 FHR-5 均与质粒 DNA 和人基因组 DNA 结合,两种 FHR 蛋白均抑制 FH-DNA 相互作用。由于 FHR 存在时 FH 与 DNA 的结合减少,FHR-1 和 FHR-5 抑制了 FH 共因子活性。两种 FHR 蛋白均导致 DNA 上补体激活增加。FHR-1 和 FHR-5 与晚期凋亡和坏死细胞结合,并募集单体 C 反应蛋白和 pentraxin 3。FHR 与 pentraxins 的相互作用导致在人血清暴露下,死细胞上经典和替代补体途径的激活增强。总的来说,我们的研究结果表明,FHR-1 和 FHR-5 是 DNA 上 FH 的竞争性抑制剂;此外,FHR-pentraxin 相互作用促进了死亡细胞的调理作用。